One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based on entry serum bilirubin (<2 mg/dL vs. 2 mg/dL or greater) and liver histology (stages I, 1 1 vs. stages 111, IV-Ludwig criteria) were randomized within each stratum to ursodiol or placebo given in a s
β¦ LIBER β¦
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis*1
β Scribed by COMBES, B
- Book ID
- 122921647
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 875 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A randomized, double-blind, placebo-cont
β
Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Danyu Lin; Dr Mary F.
π
Article
π
1995
π
John Wiley and Sons
π
English
β 792 KB
The canadian multicenter double-blind ra
β
E. Jenny Heathcote; Karen Cauch-Dudek; Valery Walker; Robert J. Bailey; Laurence
π
Article
π
1994
π
John Wiley and Sons
π
English
β 969 KB
Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic. Ursodeoxycholic acid is the least-known hepatotoxic bile acid, h
A multi-center double-blind controlled t
β
Oka, Hiroshi ;Toda, Gotaro ;Ikeda, Yusei ;Hashimoto, Naoaki ;Hasumura, Yasushi ;
π
Article
π
1990
π
Springer-Verlag
π
English
β 566 KB
A randomized placebo-controlled trial wi
π
Article
π
1994
π
Elsevier Science
π
English
β 135 KB
A placebo-controlled trial of primary bi
β
Matti Vuoristo; Martti FΓ€arkkilΓ€; Anna-Liisa Karvonen; Rauli Leino; Juhani Lehto
π
Article
π
1995
π
Elsevier Science
π
English
β 864 KB
Long-term effects of ursodeoxycholic aci
β
Albert ParΓ©s; LlorenΓ§ CaballerΓa; Juan RodΓ©s; Miquel Bruguera; Luis Rodrigo; Ant
π
Article
π
2000
π
Elsevier Science
π
English
β 818 KB